CELGENE LIMITED
Get an alert when CELGENE LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-05-20
Overdue
Watchouts
Cash
—
Latest balance sheet
Net assets
£2
0% vs 2023
Employees
0
Average over period
Profit before tax
—
Period ending 2024-12-31
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Confirmation statement overdue
Due 2026-05-20.
-
Material uncertainty over going concern
The directors have prepared the financial statements on a basis other than going concern. Further details can be found in note 2.3 to the financial statements.
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | -£992,256 | -£992,256 | |
| Profit before tax | £3,464,807 | — | |
| Net profit | £2,433,760 | £0 | |
| Cash | — | — | |
| Total assets less current liabilities | — | — | |
| Net assets | £2 | £2 | |
| Equity | £2 | £2 | |
| Average employees | 0 | 0 | |
| Wages | — | — | |
| Directors' remuneration | £0 | £0 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
—
Not reported
-
Cash
—
Not reported
-
Net assets
0%
£2 £2
-
Employees
—
Not reported
-
Operating profit
0%
-£992,256 -£992,256
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Current ratio | 1.00x | 1.00x |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- CELGENE LIMITED 2006-05-18 → present
- CELGENE UK MARKETING LIMITED 2005-06-02 → 2006-05-18
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Audit opinion
- Unaudited (audit-exempt)
- Going concern
- Material uncertainty disclosed
“The directors have prepared the financial statements on a basis other than going concern. Further details can be found in note 2.3 to the financial statements.”
Significant events
- “From 1 October 2022, the company was a non-trading entity. The company's trade, assets and liabilities were transferred on 1 October 2022 to Bristol-Myers Squibb Pharmaceuticals Limited. The directors plan to liquidate the company during the financial year of 2026.”
- “There have been no significant events since the year end that require adjustment to or disclosure in the financial statements.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
1 active · 29 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| ONG, Annie | Director | 2023-11-08 | Apr 1974 | Malaysian |
Show 29 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CITCO MANAGEMENT (UK) LIMITED | Corporate Secretary | 2011-02-03 | 2025-06-15 |
| COMAT CONSULTING SERVICES LIMITED | Corporate Secretary | 2005-06-02 | 2011-02-02 |
| ALLMOND, David James | Director | 2006-10-20 | 2008-10-01 |
| BAZARKO, Daniel Adrian | Director | 2012-02-20 | 2013-06-07 |
| BILLER, Jonathan Prim | Director | 2012-02-20 | 2019-02-20 |
| BROUWER, Aart | Director | 2006-10-20 | 2011-05-16 |
| COLOWICK, Alan Burton | Director | 2012-02-20 | 2014-09-15 |
| COOKE, John Scott | Director | 2021-07-20 | 2023-11-08 |
| FLANIGAN III, Patrick Eugene | Director | 2019-02-20 | 2019-11-26 |
| GUJER, Remo | Director | 2017-01-01 | 2019-11-26 |
| HOCH, Lynelle B. | Director | 2019-11-26 | 2021-07-20 |
| HUGIN, Robert | Director | 2005-06-02 | 2006-10-20 |
| JABLONSKI, Kimberly Mccutcheon | Director | 2022-01-19 | 2026-01-28 |
| JASKO, Stephen | Director | 2005-06-02 | 2008-09-05 |
| KELLY, Katherine Reynolds | Director | 2019-11-26 | 2021-09-17 |
| MAHATME, Sandesh | Director | 2006-10-20 | 2012-02-20 |
| MORRISSEY, Michael | Director | 2005-06-02 | 2006-10-20 |
| OEHEN, Jurg | Director | 2006-10-20 | 2019-02-20 |
| PATSI, Tuomo Tapani | Director | 2014-09-15 | 2020-04-30 |
| PATSI, Tuomo Tapani | Director | 2009-06-30 | 2010-07-16 |
| PEARCE, Samantha Jane Laura | Director | 2011-05-16 | 2014-11-17 |
| PIGNOLET, David Walter | Director | 2019-02-20 | 2022-01-19 |
| ROBERTSON, Andrew Howard | Director | 2008-10-01 | 2009-06-30 |
| SERRY, Nakisa | Director | 2013-06-07 | 2020-04-30 |
| SOUVERIJNS, Wim Jozef Maria Guido | Director | 2014-11-17 | 2016-11-21 |
| VAN HOEK, Andre Laurent Elisabeth Maria | Director | 2008-09-05 | 2012-02-20 |
| VAN HOLLE, Phiippe Marie Marcel Joseph | Director | 2006-10-20 | 2012-02-20 |
| VARGAS QUINTAS CAMPOS, Teresa Maria | Director | 2020-04-30 | 2022-10-03 |
| WATTERS, Kenneth John, Dr | Director | 2005-06-02 | 2006-10-20 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Bristol-Myers Squibb Pharmaceuticals Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2022-07-31 | Active |
| Celgene Uk Manufacturing (Ii) Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Ceased 2022-07-31 |
Filing timeline
Last 20 of 159 total filings
Material constitutional events — rename, articles re-file, resolution
- 2023-09-29 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-01-30 | TM01 | officers | Termination director company with name termination date | |
| 2026-01-20 | AA | accounts | Accounts with accounts type full | |
| 2025-06-30 | AD02 | address | Change sail address company with old address new address | |
| 2025-06-30 | TM02 | officers | Termination secretary company with name termination date | |
| 2025-05-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-10-10 | AA | accounts | Accounts with accounts type full | |
| 2024-05-21 | RP04CS01 | confirmation-statement | Second filing of confirmation statement with made up date | |
| 2024-05-15 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-11-17 | TM01 | officers | Termination director company with name termination date | |
| 2023-11-17 | AP01 | officers | Appoint person director company with name date | |
| 2023-09-29 | SH19 | capital | Capital statement capital company with date currency figure | |
| 2023-09-29 | SH20 | capital | Legacy | |
| 2023-09-29 | CAP-SS | insolvency | Legacy | |
| 2023-09-29 | RESOLUTIONS | resolution | Resolution | |
| 2023-08-07 | AA | accounts | Accounts with accounts type full | |
| 2023-07-24 | CH01 | officers | Change person director company with change date | |
| 2023-05-19 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-10-03 | TM01 | officers | Termination director company with name termination date | |
| 2022-09-29 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2022-09-23 | AD01 | address | Change registered office address company with date old address new address |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.